Posts by detchison_detchison
BIO: What happened with the Orphan Drug Tax Credit
BIO: What happened with the Orphan Drug Tax Credit During a busy week in Congress, Democrats included a change to the Orphan Drug Tax Credit that would negatively impact research on rare diseases affecting millions of Americans. The U.S. House of Representatives has several committees marking up the Senate’s $3.5 trillion budget reconciliation package. (Here’s…
Read MoreBIO’s fall Congressional preview
The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry.
Read MoreLife Science Caucus focuses on supporting innovative agricultural tech
Life Science Caucus focuses on supporting innovative agricultural tech Rep. Donna McDowell White welcomes attendees NCBIO President Laura Gunter Scott Uknes, Ph.D., co-founder and co-CEO of AgBiome John Fleming, a farmer and partner with Fleming Brothers Farms, LLC in Halifax Sinnovatek President and CEO Michael Drug T. Y. Baker and Yates Baker, father and son…
Read MoreNCBIO Roadmap to Diversity offers strategies for building diverse and inclusive organizations
NCBIO Roadmap to Diversity offers strategies for building diverse and inclusive organizations View Agenda (0.4MB PDF) View keynote slide deck (2.6MB PDF) NCBIO hosted its first event in the Roadmap to Diversity in Life Sciences series on Tuesday, Aug. 24, featuring experts in diversity, equity and inclusion from a number of North Carolina life sciences…
Read MoreBIO: Where things stand with TRIPS waiver
BIO: Where things stand with TRIPS waiver It’s been a while since we’ve talked about what’s going on at the WTO. Here’s the latest news—and why the proposed waiver of vaccine IP is still a bad idea. The status: The World Trade Organization is still considering a proposal backed by India and South Africa (and…
Read MoreNCBIO members inform state legislators at July Life Science Caucus meeting
Representatives from G1 Therapeutics, United Therapeutics and Thermo Fisher Scientific shared insights from their companies with members of the North Carolina General Assembly’s Life Science Caucus on during its meeting held Wednesday, July 21
Read MoreNCBIO forum offers guidance on creating new lab space
When it comes to creating lab space for a new or established business, getting your team together early and allowing plenty of time to plan are the keys to success, according to panelists assembled for NCBIO’s Lab Space Forum held online Tuesday, July 13.
Read MoreLaura Gunter named new NCBIO president
Laura Gunter named new NCBIO president Laura Gunter Laura Gunter, M.B.A, has been selected as the new president of NCBIO, the N.C. Biosciences Organization, succeeding longtime president Sam Taylor who died in February. Gunter has served as the organization’s executive vice president since 2020 and has filled the executive role since Taylor’s death. Gunter joined…
Read MoreNCBIO to create NC Community Colleges scholarships honoring longtime president Sam Taylor
NCBIO to create NC Community Colleges scholarships honoring longtime president Sam Taylor Sam Taylor NCBIO, the NC Biosciences Organization, is raising funds to create the Samuel M. Taylor Memorial Life Sciences Scholarship in the North Carolina Community Colleges Foundation to provide scholarships for students pursuing training and careers in the life sciences in North Carolina.…
Read More2021 BIO Digital Roundup
2021 BIO Digital Roundup BIO Digital 2021 spotlighted biotech’s transformative role and impact on today’s four key challenges: COVID, social justice, the economy and climate change. NCBIO brings you this summary of the speakers and sessions that made the event so important. Click the link that follows each day’s description to read more in-depth coverage…
Read More